PhaseBio Pharmaceuticals Inc banner

PhaseBio Pharmaceuticals Inc
OTC:PHASQ

Watchlist Manager
PhaseBio Pharmaceuticals Inc Logo
PhaseBio Pharmaceuticals Inc
OTC:PHASQ
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $49.9

Wall Street
Price Targets

PHASQ Price Targets Summary
PhaseBio Pharmaceuticals Inc

There are no price targets for PHASQ.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
PhaseBio Pharmaceuticals Inc Competitors:
Price Targets
PTCT
PTC Therapeutics Inc
28% Upside
8961
Mori Trust Sogo Reit Inc
-4% Downside
DXPE
DXP Enterprises Inc
-18% Downside
MRVL
Marvell Technology Group Ltd
49% Upside

Revenue
Forecast

3 285% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
3 285% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 1 year the compound annual growth rate for PhaseBio Pharmaceuticals Inc's revenue is 3 285%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHASQ's stock price target?
Not Available

PHASQ doesn't have any price targets made by Wall Street professionals.

Back to Top